New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous - oral solution - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: carmellose sodium cherry extract fache 5913g methyl hydroxybenzoate propyl hydroxybenzoate purified water saccharin sodium sodium hydroxide - xylocaine viscous solution is indicated for the relief of pain and discomfort associated with: · irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome · introduction of instruments and catheters into the respiratory and gastrointestinal tract.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoire aguettant - lidocaine hydrochloride monohydrate 21,33 mg/ml - eq. lidocaine hydrochloride 20 mg/ml - solution for injection in pre-filled syringe - 20 mg/ml - lidocaine hydrochloride monohydrate 21.33 mg/ml - lidocaine

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - lidocaine hydrochloride monohydrate - solution for injection/infusion - 20 milligram(s)/millilitre - lidocaine

New Zealand - English - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to lidocaine hydrochloride 2% w/v;  ;   - oral topical gel - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3 mg/ml equivalent to lidocaine hydrochloride 2% w/v     excipient: amaranth blackcurrant flavour 017842 carmellose sodium hydrochloric acid purified water sodium hydroxide sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate - for the relief of pain and discomfort of mucous membranes of the mouth, pharynx and upper gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - oral liquid - excipient ingredients: sodium hydroxide; propyl hydroxybenzoate; methyl hydroxybenzoate; saccharin sodium; purified water; carmellose sodium; flavour - indicated for the relief of pain & discomfort associated with:,-irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome;,-introduction of instruments and catheters into the respiratory and gastrointestinal tract

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - lidocaine hydrochloride monohydrate 21,33 mg/ml - eq. lidocaine hydrochloride 20 mg/ml; epinephrine hydrogen tartrate 9 µg/ml - eq. epinephrine 5 µg/ml - solution for injection - lidocaine hydrochloride monohydrate 21.33 mg/ml; epinephrine bitartrate 9 µg/ml - lidocaine

United States - English - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 20 mg in 1 ml - lidocaine hydrochloride injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

United States - English - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride 20 mg in 1 ml - lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery. lidocaine hydrochloride is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. lidocaine hydrochloride should not be used in patients with stokes-adams syndrome, wolff-parkinson-white syndrome or with severe degrees of sinoatrial, atrioventricular or intraventricular block in the absence of an artificial pacemaker. although specific studies have not been conducted, lidocaine hcl has been used clinically without evidence of abuse of this drug or of psychological or physical dependence as a result of its use.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous;  ;   - solution for injection - 2 % - active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous     excipient: sodium chloride sodium hydroxide as 2m solution for ph adjustment water for injection